AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 08 April 2013 |
| Author/s |
author: Luca Gianni |
| Publication date | April 8, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |